Arbela Capital LLC/Maneos Compounding Machine Disclosure Statement

Jan. 09, 2020 9:48 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Contributor Since 2017

Pietros Maneos is the author of two poetry collections, the internationally renowned novella - The Italian Pleasures of Gabriele Paterkallos, and a work of aesthetic criticism titled American Bards & The London Reviewer. His essays have appeared in The Huffington Post, Mediterranean Poetry and Italian Americana. In addition to his literary pursuits, he is an avid real estate developer with his most noted development being Bramabella Vineyards in The Brushy Mountains of North Carolina.

Mr. Maneos is interested in the unconventional role of buy-and-hold leveraged etfs as part of one's long term compounding strategy. He has unveiled a website, to track the results of his investment strategies.

Important Disclaimer information for all material published on Seeking Alpha:

All articles are created and authored by Pietros Maneos are published and provided as an information source for investors capable of making their own investment decisions. None of the information offered should be construed to be advice or a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. The information offered is impersonal and not tailored to the investment needs of any specific person.

We cannot determine whether the content of any article or recommendation is appropriate for any specific person. Readers should contact their financial professional to discuss the suitability of any of the strategies or holdings before implementation in their portfolio. Research and information are provided for informational purposes only and are not intended for trading purposes. NEVER make an investment decision based solely on the information provided in our articles.

We may hold, purchase or sell positions in securities mentioned in our articles and will not disclose this information to subscribers, nor the time the positions in the securities were acquired. We may liquidate shares in profiled companies at any time without notice. We may also take positions inconsistent with the information and views expressed on our website.

We routinely own and trade the same securities purchased or sold for advisory clients of Arbela Capital LLC/Maneos Compounding Machine. This circumstance is communicated to our clients on an ongoing basis. We prioritize our clients’ interests above those of our corporate and personal accounts to avoid conflict and adverse selection in trading these commonly held interests.

Investing in publicly held securities is speculative and involves risk, including the possible loss of principal. Historical returns should not be used as the primary basis for investment decisions.

Commentary may contain forward looking statements which are by definition uncertain. Actual results may differ materially from our forecasts or estimations, and Arbela Capital LLC/Maneos Compounding Machine and its affiliates cannot be held liable for the use of and reliance upon the opinions, estimates, forecasts and findings in this article.

Arbela Capital LLC/Maneos Compounding Machine does not provide tax advice. The material contained herein is for informational purposes only and is not intended to replace the advice of a qualified tax advisor.

Opinions and views expressed in these articles or as part of our Marketplace Service are based on what we perceive to be reputable sources. In addition, we believe these sources to be accurate and reliable. However, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein. Readers should verify all claims and do their own due diligence before investing in any securities, including those mentioned in our articles or our marketplace service.

Arbela Capital LLC/Maneos Compounding Machine intends to use leverage (typically described as margin), thereby increasing both the possibility of gains and the risk of loss. Margin limits are capped at 2:1 or 200% of borrowings against net equity. Margin levels are anticipated to range from 0% to 200% of borrowings against net equity. Arbela Capital LLC/Maneos Compounding Machine margin rate was negotiated directly with the custodian; subscribers’ cost of margin may be higher.

Positive comments made by others should not be construed as an endorsement of the authors’ abilities as investment advisor representatives.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.